Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The futility analysis will likely occur sometime between June and September this year. I would imagine that a thumbs up from the DSMB on the futility analysis would influence big pharma's evaluation of the value and risk of apabetalone/Resverlogix. I would rather management get past the futility analysis "inflection point" before considering a deal.
